MSCI Private Capital Benchmarks Summary Q1 2025
Preview
Challenges persist in private markets despite positive performance across the board at the start of the year. In this report, we detail the asset-class returns and provide insights on performance, cash flows, valuations, industry composition and dry powder — leveraging data for over 14,500 closed-end funds globally.
Highlights:
- Buyout appeared to brush off the volatility in public-equity markets to deliver a positive return in the first quarter and, in a hopeful sign for exits, valuation multiples improved.
- Dry powder declined again and hovered at a decade-low share of capitalization, potentially indicating twin dynamics of a slowdown in fundraising and an increase in capital calls.
- Net cash flows came closer to breakeven, an encouraging development for limited partners, though distribution rates declined below 10%.
MSCI clients can access the full report on Private i®.
MSCI global closed-end fund indexes.
Read the full paper
Provide your information for instant access to our research papers.
The Cornerstones of Benchmarking Private Capital
Indexes can provide vital benchmarks for investors navigating private markets, a significant but relatively opaque investment ecosystem.
The 2025 General Partner Survey
See what roughly 100 GPs say about a tightening deal market and rising LP expectations surrounding transparency and reporting – and how those dynamics are shaping their next steps.
Put performance in context with private asset benchmarks
Understand private asset performance with MSCI’s benchmarks and indexes. Measure portfolios, justify allocations, report confidently in the private markets.
The content of this page is for informational purposes only and is intended for institutional professionals with the analytical resources and tools necessary to interpret any performance information. Nothing herein is intended to recommend any product, tool or service. For all references to laws, rules or regulations, please note that the information is provided “as is” and does not constitute legal advice or any binding interpretation. Any approach to comply with regulatory or policy initiatives should be discussed with your own legal counsel and/or the relevant competent authority, as needed.